SCICLONE PHARMACEUTICALS INC Accounts Receivable
SCICLONE PHARMACEUTICALS INC had Accounts Receivable of $48.00 million as of 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2017-08-09
- 2017-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $48.00M.
- 2017-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $46.62M.
- 2016-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $41.51M.
- 2016-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $37.75M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2017-06-30 | $48.00M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $46.62M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $41.51M 10-Q · filed 2017-08-09 | |
| 2016-09-30 | $37.75M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $35.41M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $32.43M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $39.36M 10-K · filed 2017-03-09 | |
| 2015-09-30 | $40.21M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $37.90M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $32.43M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $40.27M 10-K · filed 2016-03-11 | |
| 2014-09-30 | $33.93M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $35.77M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $32.27M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $39.77M 10-K · filed 2015-03-12 | $40.01M 10-K · filed 2014-03-17 |
| 2013-09-30 | $35.40M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $46.96M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $27.83M 10-Q · filed 2013-08-09 | |
| 2012-12-31 | $38.11M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $35.43M 10-Q/A · filed 2013-04-01 | $36.97M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $40.55M 10-Q/A · filed 2013-04-01 | $41.76M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $40.20M 10-Q/A · filed 2013-04-01 | $42.06M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $38.47M 10-Q/A · filed 2013-04-01 | $42.23M 10-K · filed 2012-03-15 |
| 2011-09-30 | $50.49M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $37.80M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $30.67M 10-K · filed 2012-03-15 |